29 April 2009

Possible diabetes breakthrough

Doctors believe they have found the key to eradicating the type of diabetes that obliges sufferers to regulate their blood glucose levels every day of their lives.

Australian doctors believe they have found the key to eradicating the type of diabetes that obliges sufferers to regulate their blood glucose levels every day of their lives, news reports say.

"We're really excited about this because there are no treatments for type 1 diabetes," Garvan Institute researcher Shane Grey told The Sydney Morning Herald.

"The only therapy we have is daily insulin injections, and they don't regulate glucose levels anywhere near as effectively as the body does itself," Grey said. "Most diabetics have blood sugar levels which are usually too high or too low, and over a period of time, this damages vital organs."

Type 1 diabetes can bring on heart disease, strokes, kidney failure, blindness and peripheral vascular disease. The genetic fault is present from birth but might not develop until adulthood.

Without daily insulin injections, diabetics can lapse into a potentially fatal coma.

Blocking diabetes
Grey and other researchers at the Sydney institute found a compound that had already been tested in humans with other auto-immune diseases that could block the cells that trigger type 1 diabetes.

"All immune cells talk to each other with various hormones, ... and we've found this drug is an inhibitor of one of those hormones," Grey said. "We've hit the nerve centre of the emerging clinical disease."

The therapy had a 100% success rate in the mice used in laboratory trials.

Too good to be true
"It does sound too good to be true," Grey said. "They all received 100-per-cent lifelong protection."

In their research, to be published in the journal Diabetes, the scientists injected the compound over six weeks into mice that had a 70-to 90%susceptibility of getting the disease.

Grey foreshadowed that those predisposed to type 1 diabetes - people with an affected parent or sibling - receiving vaccinations over a four-week period that should offer immunity.

"Even if it delays the onset of the disease by 10 years, it's still an amazing achievement," he said.

The potential breakthrough - clinical trials won't begin for about two years - was welcomed by Diabetes Australia.

Spokesman Neville Howard described the Garvan work as "an exciting step in diabetes research" that "may well lead to the prevention of type 1 diabetes."

The more common form of diabetes is type 2, which is late-onset and often brought on by lifestyle factors like a poor diet, being overweight and a lack of exercise. – (Sapa-dpa, April 2009)

Read more:
Diabetes Centre

Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Diabetes expert

Dr. May currently works as a fulltime endocrinologist and has been in private practice since 2004. He has a variety of interests, predominantly obesity and diabetes, but also sees patients with osteoporosis, thyroid disorders, men's health disorders, pituitary and adrenal disorders, polycystic ovaries, and disorders of growth. He is a leading member of several obesity and diabetes societies and runs a trial centre for new drugs.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules